Report

Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin

+ See all authors and affiliations

Science  13 Nov 1998:
Vol. 282, Issue 5392, pp. 1324-1327
DOI: 10.1126/science.282.5392.1324

You are currently viewing the abstract.

View Full Text

Abstract

The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clinical trials as an anticancer agent. The molecular target of fumagillin is methionine aminopeptidase-2 (MetAP-2). A 1.8 Å resolution crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2. Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide additional affinity. Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity. The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.

  • * To whom correspondence should be addressed. E-mail: jcc12{at}cornell.edu

View Full Text